ImageneBio, Inc. (IMA)
4.165
+0.06
(+1.59%)
USD |
NASDAQ |
Nov 05, 16:00
ImageneBio Price to Book Value : 0.3307 for Nov. 5, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 05, 2026 | 0.3307 |
| November 04, 2026 | 0.3255 |
| November 03, 2026 | 0.3191 |
| November 02, 2026 | 0.3247 |
| October 30, 2026 | 0.3255 |
| October 29, 2026 | 0.3215 |
| October 28, 2026 | 0.3334 |
| October 27, 2026 | 0.3191 |
| October 26, 2026 | 0.3215 |
| October 23, 2026 | 0.335 |
| October 22, 2026 | 0.3211 |
| October 21, 2026 | 0.3243 |
| October 20, 2026 | 0.3279 |
| October 19, 2026 | 0.3176 |
| October 16, 2026 | 0.3207 |
| October 15, 2026 | 0.3199 |
| October 14, 2026 | 0.3295 |
| October 13, 2026 | 0.3366 |
| October 12, 2026 | 0.3374 |
| October 09, 2026 | 0.3366 |
| October 08, 2026 | 0.3382 |
| October 07, 2026 | 0.366 |
| October 06, 2026 | 0.3652 |
| October 05, 2026 | 0.3731 |
| October 02, 2026 | 0.3652 |
| Date | Value |
|---|---|
| October 01, 2026 | 0.3636 |
| September 30, 2026 | 0.3636 |
| September 29, 2026 | 0.3636 |
| September 28, 2026 | 0.3684 |
| September 25, 2026 | 0.3747 |
| September 24, 2026 | 0.37 |
| September 23, 2026 | 0.3842 |
| September 22, 2026 | 0.385 |
| September 21, 2026 | 0.3819 |
| September 18, 2026 | 0.3882 |
| September 17, 2026 | 0.3985 |
| September 16, 2026 | 0.3914 |
| September 15, 2026 | 0.3906 |
| September 14, 2026 | 0.3969 |
| September 11, 2026 | 0.4033 |
| September 10, 2026 | 0.3973 |
| September 09, 2026 | 0.3977 |
| September 08, 2026 | 0.4009 |
| September 04, 2026 | 0.385 |
| September 03, 2026 | 0.3878 |
| September 02, 2026 | 0.3938 |
| September 01, 2026 | 0.3985 |
| August 31, 2026 | 0.4049 |
| August 28, 2026 | 0.4239 |
| August 27, 2026 | 0.4231 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 2.759 |
| Alnylam Pharmaceuticals, Inc. | 5.897 |
| Anika Therapeutics, Inc. | 1.638 |
| Savara, Inc. | 6.620 |
| Vericel Corp. | 7.061 |
Price to Book Value Related Metrics
| Price | 4.165 |
| Earnings Yield | -124.8% |
| Market Cap | 46.98M |